BSE Live
Dec 26, 16:01Prev. Close
1737.50
Open Price
1727.20
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 26, 15:54Prev. Close
1737.00
Open Price
1737.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
1719.50 (503)
| Key Financial Ratios of Sun Pharmaceutical Industries (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 15.70 | 11.10 | 9.00 | 29.00 | 18.90 | |
| Diluted EPS (Rs.) | 15.70 | 11.10 | 9.00 | 29.00 | 18.90 | |
| Cash EPS (Rs.) | 26.01 | 20.68 | 17.23 | 37.93 | 27.82 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 204.75 | 186.40 | 174.99 | 168.51 | 154.03 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 204.75 | 186.40 | 174.99 | 168.51 | 154.03 | |
| Revenue from Operations/Share (Rs.) | 136.86 | 121.14 | 110.10 | 130.49 | 118.37 | |
| PBDIT/Share (Rs.) | 31.78 | 30.56 | 26.87 | 44.65 | 36.63 | |
| PBIT/Share (Rs.) | 23.23 | 23.26 | 20.62 | 39.38 | 32.32 | |
| PBT/Share (Rs.) | 20.88 | 15.88 | 14.50 | 37.71 | 27.30 | |
| Net Profit/Share (Rs.) | 17.45 | 13.38 | 10.98 | 32.66 | 23.51 | |
| NP After MI And SOA / Share (Rs.) | 15.69 | 11.11 | 9.01 | 29.03 | 18.89 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 23.22 | 25.22 | 24.40 | 34.21 | 30.94 | |
| PBIT Margin (%) | 16.97 | 19.19 | 18.72 | 30.17 | 27.30 | |
| PBT Margin (%) | 15.25 | 13.10 | 13.17 | 28.89 | 23.06 | |
| Net Profit Margin (%) | 12.75 | 11.04 | 9.97 | 25.02 | 19.85 | |
| NP After MI And SOA Margin (%) | 11.46 | 9.17 | 8.18 | 22.24 | 15.95 | |
| Return on Networth/Equity (%) | 8.31 | 6.43 | 5.67 | 19.00 | 13.78 | |
| Return on Capital Employed (%) | 10.60 | 11.78 | 11.13 | 21.70 | 18.35 | |
| Return on Assets (%) | 5.51 | 4.12 | 3.36 | 11.34 | 8.18 | |
| Total Debt/Equity (X) | 0.17 | 0.24 | 0.26 | 0.22 | 0.25 | |
| Asset Turnover Ratio (%) | 0.49 | 0.45 | 0.42 | 0.54 | 0.54 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 2.02 | 1.79 | 1.59 | 1.84 | 2.28 | |
| Quick Ratio (X) | 1.51 | 1.34 | 1.25 | 1.46 | 1.79 | |
| Inventory Turnover Ratio (X) | 0.70 | 0.78 | 0.65 | 0.77 | 0.69 | |
| Dividend Payout Ratio (NP) (%) | 36.62 | 17.97 | 36.90 | 3.45 | 15.88 | |
| Dividend Payout Ratio (CP) (%) | 23.70 | 10.84 | 21.78 | 2.92 | 12.93 | |
| Earnings Retention Ratio (%) | 63.38 | 82.03 | 63.10 | 96.55 | 84.12 | |
| Cash Earnings Retention Ratio (%) | 76.30 | 89.16 | 78.22 | 97.08 | 87.07 | |
| Coverage Ratios | ||||||
| Interest Coverage Ratios (%) | 25.19 | 13.21 | 12.46 | 26.79 | 16.85 | |
| Interest Coverage Ratios (Post Tax) (%) | 25.19 | 13.21 | 12.46 | 26.79 | 16.85 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 89,454.34 | 120,917.76 | 122,567.89 | 161,740.88 | 196,428.86 | |
| EV/Net Operating Revenue (X) | 2.72 | 4.16 | 4.64 | 5.17 | 6.90 | |
| EV/EBITDA (X) | 11.73 | 16.49 | 19.01 | 15.10 | 22.28 | |
| MarketCap/Net Operating Revenue (X) | 2.57 | 3.96 | 4.50 | 5.27 | 6.92 | |
| Retention Ratios (%) | 63.37 | 82.02 | 63.09 | 96.54 | 84.11 | |
| Price/BV (X) | 1.87 | 2.78 | 3.12 | 4.50 | 5.98 | |
| Price/Net Operating Revenue | 2.57 | 3.96 | 4.50 | 5.27 | 6.92 | |
| Earnings Yield | 0.04 | 0.02 | 0.02 | 0.04 | 0.02 |
20.11.2025
12.11.2025
11.11.2025
Buy Sun Pharmaceutical Industries; target of Rs 1875 Prabhudas Lilladher
11.11.2025
Sun Pharma Standalone September 2025 Net Sales at Rs 4,548.11 crore, down 11.3% Y-o-Y
11.11.2025
Sun Pharma Standalone September 2025 Net Sales at Rs 4,548.11 crore, down 11.3% Y-o-Y
01.08.2025
Sun Pharma Consolidated June 2025 Net Sales at Rs 13,851.40 crore, up 9.47% Y-o-Y
31.07.2025
Sun Pharma Standalone June 2025 Net Sales at Rs 5,601.96 crore, up 24.54% Y-o-Y
22.05.2025
Sun Pharma Q4 net profit declines 19% to Rs 2,154 crore, firm declares Rs 5.50 dividend